Article Details
Retrieved on: 2021-07-10 11:32:37
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Moderna (NASDAQ:MRNA)'s stock had its "buy" rating restated by equities research analysts at Chardan Capital in a research note issued to investors ...
Article found on: www.marketbeat.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here